Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

To explore whether exhaled nitric oxide (FeNO) non-suppression identifies corticosteroid resistance, we analysed inflammatory mediator changes during a FeNO suppression test with monitored high-intensity corticosteroid therapy. In linear mixed-effects models analysed over time, the 15 clinically-dis...

Full description

Bibliographic Details
Main Authors:	Couillard, S, Shrimanker, R, Lemaire-Paquette, S, Hynes, GM, Borg, C, Connolly, C, Thulborn, S, Moran, AM, Poole, S, Morgan, S, Powell, T, Pavord, I, Hinks, T, Couillard Castonguay, S
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2022

Similar Items

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines
by: Couillard, S, et al.
Published: (2020)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
by: Connolly, CM, et al.
Published: (2017)

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma
by: Hynes, G, et al.
Published: (2017)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
by: Couillard, S, et al.
Published: (2021)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
by: Couillard, S, et al.
Published: (2021)

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework
by: Couillard, S, et al.
Published: (2022)

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
by: Oliver, ME, et al.
Published: (2021)

Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort
by: Gittins, A, et al.
Published: (2018)

Biological therapies for asthma
by: Couillard Castonguay, S, et al.
Published: (2021)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
by: Moran, AM, et al.
Published: (2020)

Asthma in pregnancy: An update
by: Couillard, S, et al.
Published: (2020)

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
by: Couillard Castonguay, S, et al.
Published: (2022)

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
by: Moran, A, et al.
Published: (2020)

Fractional exhaled nitric oxide non-suppression in asthma
by: Couillard Castonguay, S
Published: (2021)

Evaluating the sensitivity and specificity of Neatstik® technology compared to an activity-based immunoassay in sputum samples
by: Thulborn, S, et al.
Published: (2018)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma
by: Couillard, S, et al.
Published: (2022)

Identification of pulmonary treatable traits in a real-life setting
by: Simpson, J, et al.
Published: (2018)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
by: Hynes, G, et al.
Published: (2018)

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
by: Couillard, S, et al.
Published: (2021)

The Lancet COPD Commission: broader questions remain
by: Petousi, N, et al.
Published: (2023)

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
by: Couillard, S, et al.
Published: (2021)

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
by: Simon Couillard, et al.
Published: (2021-02-01)

How I do it: workup of severe asthma
by: Couillard, S, et al.
Published: (2021)

Blood eosinophils, fractional exhaled nitric oxide, and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
by: Couillard, S, et al.
Published: (2022)

Identifying bacterial airways infection in stable severe asthma using Oxford nanopore sequencing technologies
by: Jabeen, MF, et al.
Published: (2022)

To what extent does the prototype ORACLE scale predict treatment benefits? Predicted versus observed impact of anti-inflammatory treatments
by: Couillard, S, et al.
Published: (2021)

Antibiotics for asthma attacks: masking uncertainty
by: Ramakrishnan, S, et al.
Published: (2021)

Things, Assemblages, Worlds: Locating Vibrancy Beyond a Subject-Object Relationship (A Tale of Disposition)
by: Paul Couillard
Published: (2023-12-01)

Fiona Couillard
by: Fiona Couillard
Published: (2021-05-01)

Sputum induction to assess airway inflammation: is it an inflammatory stimulus?
by: Pavord, I
Published: (1998)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
by: Green, R, et al.
Published: (2002)

Sputum eosinophilia in idiopathic pulmonary fibrosis.
by: Birring, S, et al.
Published: (2005)

COMMUNICATIONS THE PANGS OF GENDER POLITICS
by: Couillard, Marie-Andree
Published: (1991)

Carving in a Jah Hut community : tradition in tension
by: Couillard, Marie-Andree
Published: (1978)

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
by: Shrimanker, R, et al.
Published: (2019)

Measurement of Markers of Inflammation in Induced Sputum and Exhaled Air
by: Pavord, I, et al.
Published: (2009)

Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma
by: Hinks, T, et al.
Published: (2018)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
by: Bafadhel, M, et al.
Published: (2009)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
by: Rastogi, S, et al.
Published: (2017)